Advertisement
Screener

CEPHALON INC Research and Development Expense (Excluding Acquired in Process Cost)

CEPHALON INC Research and Development Expense (Excluding Acquired in Process Cost)

CEPHALON INC reported Research and Development Expense (Excluding Acquired in Process Cost) of $134.85 million for the 3-month period ending 2011-06-30, per its 10-Q filed 2011-08-03.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2011-08-03

  • CEPHALON INC research and development expense (excluding acquired in process cost) for the quarter ending 2011-06-30 was $134.85M, a 33.17% increase year-over-year.
  • CEPHALON INC research and development expense (excluding acquired in process cost) for the quarter ending 2011-03-31 was $122.31M, a 16.07% increase year-over-year.
  • CEPHALON INC research and development expense (excluding acquired in process cost) for the quarter ending 2010-12-31 was $122.39M, a 34.25% increase year-over-year.
  • CEPHALON INC research and development expense (excluding acquired in process cost) for the quarter ending 2010-09-30 was $110.97M, a 11.91% increase year-over-year.
  • CEPHALON INC research and development expense (excluding acquired in process cost) for fiscal 2010 was $440.00M, a 11.27% increase from fiscal 2009.
  • CEPHALON INC research and development expense (excluding acquired in process cost) for fiscal 2009 was $395.43M, a 9.17% increase from fiscal 2008.
  • CEPHALON INC research and development expense (excluding acquired in process cost) for fiscal 2008 was $362.21M.
Period endResearch and Development Expense (Excluding Acquired in Process Cost) 3 monthResearch and Development Expense (Excluding Acquired in Process Cost) 6 monthResearch and Development Expense (Excluding Acquired in Process Cost) 9 monthResearch and Development Expense (Excluding Acquired in Process Cost) 12 month
2011-06-30$134.85M
10-Q · filed 2011-08-03
$257.16M
10-Q · filed 2011-08-03
$379.56M
derived: sum of 3 quarters · filed 2011-08-03
$490.52M
derived: sum of 4 quarters · filed 2011-08-03
2011-03-31$122.31M
10-Q · filed 2011-05-04
$244.70M
derived: sum of 2 quarters · filed 2011-05-04
$355.67M
derived: sum of 3 quarters · filed 2011-05-04
$456.93M
derived: sum of 4 quarters · filed 2011-08-03
2010-12-31$122.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-11
$233.36M
derived: sum of 2 quarters · filed 2011-02-11
$334.62M
derived: sum of 3 quarters · filed 2011-08-03
$440.00M
10-K · filed 2011-02-11
2010-09-30$110.97M
10-Q · filed 2010-10-29
$212.23M
derived: sum of 2 quarters · filed 2011-08-03
$317.60M
10-Q · filed 2010-10-29
$408.77M
derived: sum of 4 quarters · filed 2011-08-03
2010-06-30$101.26M
10-Q · filed 2011-08-03
$206.64M
10-Q · filed 2011-08-03
$297.80M
derived: sum of 3 quarters · filed 2011-08-03
$396.96M
derived: sum of 4 quarters · filed 2011-08-03
2010-03-31$105.38M
10-Q · filed 2011-05-04
$196.54M
derived: sum of 2 quarters · filed 2011-05-04
$295.70M
derived: sum of 3 quarters · filed 2011-05-04
$397.78M
derived: sum of 4 quarters · filed 2011-05-04
2009-12-31$91.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-11
$190.32M
derived: sum of 2 quarters · filed 2011-02-11
$292.41M
derived: sum of 3 quarters · filed 2011-02-11
$395.43M
10-K · filed 2011-02-11
2009-09-30$99.16M
10-Q · filed 2010-10-29
$201.24M
derived: sum of 2 quarters · filed 2010-10-29
$304.27M
10-Q · filed 2010-10-29
2009-06-30$102.08M
10-Q · filed 2010-07-28
$205.11M
10-Q · filed 2010-07-28
2008-12-31$362.21M
10-K · filed 2011-02-11